
LTM 250mg Tablet
Marketer
Biotanic Pharmaceuticals
Salt Composition
Levetiracetam (250mg)
Overview LTM 250mg Tablet
Epileptic seizures are managed by the anticonvulsant medication, EpsiTab 250mg. This medication, administered alone or in conjunction with other treatments, controls seizures while consistently taken. EpsiTab 250mg works by reducing abnormal brain electrical activity. Dosage is tailored to individual needs and response, determined by your physician, and typically involves long-term use. Consistent daily dosing, ideally at the same time, maximizes efficacy; food intake doesn't affect administration. Discontinuing or missing doses can worsen seizures; therefore, continue as prescribed, even if feeling well. Common, usually transient, side effects may include drowsiness, headache, appetite changes, irritability, and altered behavior, including aggression. While most side effects resolve spontaneously, some may require medical attention. Rarely, suicidal ideation has been reported; notify your doctor of any significant mood shifts. Prior to commencing treatment, inform your doctor of any existing kidney issues, depression, suicidal tendencies, pregnancy, pregnancy plans, or breastfeeding. Regular blood tests to assess kidney function may be recommended during treatment.
Uses of LTM 250mg Tablet
Managing Epileptic Seizures
Major Benefits of LTM 250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 250mg LTM Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of LTM 250mg Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use LTM 250mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 250mg LTM Tablet can be consumed with or without food, although consistent timing is recommended.
How LTM 250mg Tablet works:
Levetiracetam 250mg tablets are used to control seizures. Their mechanism involves binding to synaptic vesicle protein 2A (SV2A) receptors on neurons. This action reduces excessive neuronal firing in the brain, thereby hindering the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking LTM 250mg Tablets.
PregnancySAFE IF PRESCRIBED
The 250mg LTM tablet poses minimal to no known developmental risk to the fetus during pregnancy, according to the majority of research.
Breast feedingSAFE IF PRESCRIBED
Administering LTM 250mg tablets while breastfeeding is likely safe. Available human data indicates minimal infant risk. Observe the infant for drowsiness and appropriate weight increase.
DrivingUNSAFE
Taking a 250mg LTM tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with kidney impairment, the administration of 250mg LTM tablets requires careful monitoring. Dosage modification of LTM 250mg tablets may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of LTM 250mg Tablets in individuals with liver impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, consultation with a physician is recommended. Patients experiencing severe hepatic dysfunction might benefit from a reduced dosage.
What if you forget to take LTM 250mg Tablet :
Should you forget a LTM 250mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About LTM 250mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Pyrrolidinone-based and acetamide-derived compounds. |
| Potential for Dependence | None. |
| Type of Medication | Nervous system medications. |
| Mechanism of Action | Vesicle-associated protein 2, a ligand for anti-epileptic drugs. |
